FDA Approves First Biosimilar Insulin Product

THURSDAY, July 29, 2021 -- The first interchangeable biosimilar insulin product has been approved by the U.S. Food and Drug Administration, providing patients with a cost-effective option for treating diabetes, the agency announced...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news